Reperfusion Therapy’s Broad Benefit: Refining Stroke Treatment Criteria
A major multicenter registry analysis in the Annals of Clinical and Translational Neurology provides new insights into patient selection for endovascular thrombectomy (MT) in acute ischemic stroke. The study, involving over 5,400 patients, evaluated how functional outcomes after successful reperfusion varied when patients were stratified by admission stroke severity (NIHSS) and brain imaging scores (ASPECTS). The findings confirm that successful reperfusion, especially achieving a complete mTICI 3 recanalization, is associated with significantly improved functional recovery across all patient subgroups. Notably, the greatest absolute benefit was observed in patients with a pronounced “clinical-core mismatch”—severe symptoms but limited early ischemic changes on imaging—where successful reperfusion increased the rate of good outcomes by 38 percentage points.
Study Significance: For pharmacologists and clinicians involved in acute neurovascular care and the development of adjunctive drug therapies, this research underscores the critical importance of achieving complete reperfusion. The data supports a move toward more individualized treatment paradigms, potentially expanding the therapeutic window for intervention. This has direct implications for designing clinical trials for new neuroprotective agents or thrombolytics meant to be used alongside mechanical thrombectomy, as the patient population likely to benefit may be broader than previously defined.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
